Differential Infectivity of Human Neural Cell Lines by a Dengue Virus Serotype-3 Genotype-III with a Distinct Nonstructural Protein 2A (NS2A) Amino Acid Substitution Isolated from the Cerebrospinal Fluid of a Dengue Encephalitis Patient

Dengue encephalitis is considered as a severe but unusual clinical presentation of dengue infection. Limited molecular information is available on the neurotropism of dengue virus (DENV), highlighting the need for further research. During a dengue outbreak in Vietnam in 2013, two DENV-3 strains were isolated, in which one was isolated from cerebrospinal fluid (CSF) samples from a dengue encephalitis patient and another strain was isolated from a patient with classical dengue fever in Hai Phong, Vietnam. DENV serotype-3 (DENV-3) isolated from these samples belonged to genotype III, marking the first report of this genotype in the country at that time. Genetic variation between both strains was elucidated by using a full genome sequencing by next-generation sequencing (NGS). The infectivity of the isolated DENV-3 strains was further characterized using human and mouse neuronal cell lines. Phylogenetic analysis of the isolates demonstrated high homogeneity between the CSF-derived and serum-derived DENV-3, in which the full genome sequences of the CSF-derived DENV-3 presented a Thr-1339-Ile mutation in the nonstructural 2A (NS2A) protein. The CSF-derived DENV-3 isolate grew preferentially in human neuronal cells, with a significant proportion of cells that were positive for nonstructural 1 (NS1), nonstructural 4B (NS4B), and nonstructural 5 (NS5) antigens. These results suggest that NS2A may be a crucial region in the neuropathogenesis of DENV-3 and its growth in human neuronal cells. Taken together, our results demonstrate that a CSF-derived DENV-3 has unique infectivity characteristics for human neuronal cells, which might play a crucial role in the neuropathogenesis of DENV infection.

[1]  K. Ikuta,et al.  Construction of a high-yield dengue virus by replacing nonstructural proteins 3-4B without increasing virulence. , 2018, Biochemical and biophysical research communications.

[2]  Guo-hong Li,et al.  Neurological Manifestations of Dengue Infection , 2017, Front. Cell. Infect. Microbiol..

[3]  S. Ching,et al.  Acute disseminated encephalomyelitis in dengue viral infection , 2017, Journal of Clinical Neuroscience.

[4]  Yee‐Shin Lin,et al.  Dengue virus infection increases microglial cell migration , 2017, Scientific Reports.

[5]  J. Castellanos,et al.  In Vitro Infection with Dengue Virus Induces Changes in the Structure and Function of the Mouse Brain Endothelium , 2016, PloS one.

[6]  L. Ng,et al.  Epidemic resurgence of dengue fever in Singapore in 2013-2014: A virological and entomological perspective , 2016, BMC Infectious Diseases.

[7]  R. Sang,et al.  Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay , 2016, Clinical and Vaccine Immunology.

[8]  A. A. Pinevich,et al.  CHARACTERISTICS OF A172 AND T98G CELL LINES. , 2016, Tsitologiia.

[9]  T. Nabeshima,et al.  Isolation of dengue serotype 3 virus from the cerebrospinal fluid of an encephalitis patient in Hai Phong, Vietnam in 2013. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[10]  Y. Ou,et al.  Disruption of in vitro endothelial barrier integrity by Japanese encephalitis virus‐Infected astrocytes , 2015, Glia.

[11]  R. Garg,et al.  Neurologic complications in dengue virus infection , 2014, Neurology.

[12]  A. Shriram,et al.  Dengue virus serotype-3 (subtype-III) in Port Blair, India. , 2014, Journal of vector borne diseases.

[13]  O. Faye,et al.  Urban Epidemic of Dengue Virus Serotype 3 Infection, Senegal, 2009 , 2014, Emerging infectious diseases.

[14]  Kalakatawi H Mamdouh,et al.  Atypical Dengue Meningitis in Makkah, Saudi Arabia with Slow Resolving, Prominent Migraine like Headache, Phobia, and Arrhythmia , 2013, Journal of global infectious diseases.

[15]  J. Farrar,et al.  Neurological complications of dengue virus infection , 2013, The Lancet Neurology.

[16]  A. Wilder-Smith,et al.  Epidemiology of dengue: past, present and future prospects , 2013, Clinical epidemiology.

[17]  L. Luo,et al.  Molecular characterization of the envelope gene of dengue virus type 3 newly isolated in Guangzhou, China, during 2009-2010. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[18]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[19]  N. Malhotra,et al.  Isolated Bell's palsy - an unusual presentation of dengue infection. , 2013, Asian Pacific journal of tropical medicine.

[20]  Y. Leo,et al.  Clinico-genetic characterisation of an encephalitic Dengue virus 4 associated with multi-organ involvement. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  M. Orsini,et al.  Dengue: a new challenge for neurology , 2012, Neurology international.

[22]  Ramón Doallo,et al.  CircadiOmics: integrating circadian genomics, transcriptomics, proteomics and metabolomics , 2012, Nature Methods.

[23]  O. Ullah,et al.  Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan , 2011, BMC Microbiology.

[24]  Qiyong Liu,et al.  Dengue Virus Serotype 3 Subtype III, Zhejiang Province, China , 2011, Emerging infectious diseases.

[25]  J. Murthy Neurological complication of dengue infection. , 2010, Neurology India.

[26]  O. Gascuel,et al.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.

[27]  J. M. Peralta,et al.  Meningitis determined by oligosymptomatic dengue virus type 3 infection: report of a case. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[28]  J. M. Peralta,et al.  Neurologic dengue manifestations associated with intrathecal specific immune response , 2009, Neurology.

[29]  C. Pannuti,et al.  Involvement of the central nervous system in patients with dengue virus infection , 2008, Journal of the Neurological Sciences.

[30]  S. Zanata,et al.  Dengue neurovirulence in mice: identification of molecular signatures in the E and NS3 helicase domains , 2007, Journal of medical virology.

[31]  J. M. Peralta,et al.  Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis , 2006, Journal of the Neurological Sciences.

[32]  Hiroyuki Toh,et al.  Improvement in the accuracy of multiple sequence alignment program MAFFT. , 2005, Genome informatics. International Conference on Genome Informatics.

[33]  N. Phuong,et al.  Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. , 2001, The American journal of tropical medicine and hygiene.

[34]  U. Thisyakorn,et al.  Neurological manifestations in dengue patients. , 2001, The Southeast Asian journal of tropical medicine and public health.

[35]  N. M. Dung,et al.  Neurological manifestations of dengue infection , 2000, The Lancet.

[36]  C. Ramos,et al.  Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. , 1998, Journal of neurovirology.

[37]  H. Schatzmayr,et al.  Retrospective study on dengue fatal cases. , 1997, Clinical neuropathology.

[38]  I. Sánchez,et al.  A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. , 1996, The Journal of general virology.

[39]  S. Lam,et al.  Dengue encephalitis: a true entity? , 1996, The American journal of tropical medicine and hygiene.

[40]  C. Lai,et al.  Genetic determinants of dengue type 4 virus neurovirulence for mice , 1993, Journal of virology.